CN101279995A - Tripterine salt, preparation and use thereof - Google Patents
Tripterine salt, preparation and use thereof Download PDFInfo
- Publication number
- CN101279995A CN101279995A CNA2007100141546A CN200710014154A CN101279995A CN 101279995 A CN101279995 A CN 101279995A CN A2007100141546 A CNA2007100141546 A CN A2007100141546A CN 200710014154 A CN200710014154 A CN 200710014154A CN 101279995 A CN101279995 A CN 101279995A
- Authority
- CN
- China
- Prior art keywords
- tripterine
- salt
- preparation
- organic amine
- mineral alkali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007100141546A CN101279995A (en) | 2007-04-03 | 2007-04-03 | Tripterine salt, preparation and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007100141546A CN101279995A (en) | 2007-04-03 | 2007-04-03 | Tripterine salt, preparation and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101279995A true CN101279995A (en) | 2008-10-08 |
Family
ID=40012684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007100141546A Pending CN101279995A (en) | 2007-04-03 | 2007-04-03 | Tripterine salt, preparation and use thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101279995A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796254A (en) * | 2011-05-26 | 2012-11-28 | 复旦大学 | Pegylated celastrol and preparation method and application thereof |
CN110229210A (en) * | 2019-06-25 | 2019-09-13 | 河南中医药大学 | Amino acid eutectic object of Celastrol and its preparation method and application |
CN111529535A (en) * | 2012-09-27 | 2020-08-14 | 儿童医学中心公司 | Compounds for the treatment of obesity and methods of use thereof |
CN115368430A (en) * | 2022-09-02 | 2022-11-22 | 北京化工大学 | Preparation method and application of tripterine metal complex |
-
2007
- 2007-04-03 CN CNA2007100141546A patent/CN101279995A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102796254A (en) * | 2011-05-26 | 2012-11-28 | 复旦大学 | Pegylated celastrol and preparation method and application thereof |
CN111529535A (en) * | 2012-09-27 | 2020-08-14 | 儿童医学中心公司 | Compounds for the treatment of obesity and methods of use thereof |
CN110229210A (en) * | 2019-06-25 | 2019-09-13 | 河南中医药大学 | Amino acid eutectic object of Celastrol and its preparation method and application |
CN110229210B (en) * | 2019-06-25 | 2022-07-12 | 河南中医药大学 | Amino acid eutectic compound of tripterine, preparation method and application thereof |
CN115368430A (en) * | 2022-09-02 | 2022-11-22 | 北京化工大学 | Preparation method and application of tripterine metal complex |
CN115368430B (en) * | 2022-09-02 | 2024-02-02 | 北京化工大学 | Preparation method and application of tripterine metal complex |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104173272B (en) | Sustained-release preparation of isothiocyanate compounds | |
CN103880910B (en) | A kind of preparation method and its usage of Cyclosiversigenin | |
JP6209579B2 (en) | Pharmaceutical composition that is regarded as a supplementary medicine | |
CN101284823B (en) | Arctigenin pro-drug, preparation method and use thereof | |
CN105769891A (en) | Low-polarity rare ginsenoside mixture and application thereof | |
CN101279995A (en) | Tripterine salt, preparation and use thereof | |
JP6389958B2 (en) | Medicinal use of anti-tumor for rutile pentacyclic triterpene saponins | |
CN104707148A (en) | Polyethylene glycol modified glycyrrhetinic acid and curcumin compound used for resisting hepatic carcinoma, and preparation method thereof | |
JP2005519863A (en) | Flavanolignan preparation with excellent solubility | |
CA2640509C (en) | Use of gallium(iii) complexes for the treatment of melanomas | |
CN105079819B (en) | A kind of preparation method of anticoccidial Adprin hydroxypropyl beta cyclodextrin clathrate | |
CN102475698A (en) | Application of salvianolic acid L in preparation of medicines used for treating tumor | |
CA3079031C (en) | Formulation containing a-decarbonized-5-alpha androstane compound for increasing white blood cell and use thereof | |
WO2016169487A1 (en) | Use of forsythin, forsythin derivatives and composition of forsythin and forsythiaside in the preparation of anti-inflammatory drugs | |
CN1762341B (en) | Salvianolic acid compound for treating cardiovascular and cerebrovascular disease and liver disease, and application thereof | |
CN102871983B (en) | Gamlogic acid conlon targeting controlled release tablet and preparation method thereof | |
CN101584854B (en) | Romurtide cyclodextrin inclusion compound, preparation thereof and method for preparing same | |
CN102727867B (en) | Antineoplastic pharmaceutical composition and application thereof, kit and package | |
CN113164474A (en) | Water-soluble polymer derivative of Venetok | |
CN105769849B (en) | A kind of pharmaceutical composition for treating oophoroma | |
KR20200144568A (en) | Drugs, combination products, and applications for preventing and/or treating pain and/or fever | |
CN101953847B (en) | Application of zinc hydroxide in preparation of anti-cancer drugs | |
CN100421672C (en) | Compound lentinan preparation for antitumour and its preparing method | |
JP4781624B2 (en) | RANTES inducer | |
CN101264077B (en) | Lignans and its use for preparing antiphlogistic antiendotoxin medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Yantai Target Drug Research Co., Ltd. Liu Junfeng Document name: Notification that Application Deemed to be Withdrawn |
|
ASS | Succession or assignment of patent right |
Owner name: SUZHOU LEINA PHARMACEUTICAL RESEARCH + DEVELOPMENT Free format text: FORMER OWNER: YANTAI TARGET DRUG RESEARCH CO., LTD. Effective date: 20120208 |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264006 YANTAI, SHANDONG PROVINCE TO: 215125 SUZHOU, JIANGSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120208 Address after: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215125 BioBAY No. 218 building A3 room 318 Applicant after: Suzhou Leina Pharmaceutical Research Development Co., Ltd. Address before: 264006, No. 1 Longevity Hill Road, Yantai Development Zone, Shandong province (West Building of science and technology building, building 6, biology medicine building, overseas Chinese student Pioneer Park, Yantai) Applicant before: Yantai Target Drug Research Co., Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20081008 |